Active Ingredient(s):Viloxazine Hydrochloride FDA Approved: * April 2, 2021 Pharm Company: *SUPERNUS PHARMS Category:ADD / ADHD
Viloxazine, sold under the brand name Qelbree among others, is a medication which is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children and depression. It was marketed for more than two decades as an antidepressant in Europe before being repurposed as a treatment for ADHD and launched in the United States in April 2021. Viloxazine is taken by mout...
* May have multiple approval dates, manufacturers, or labelers.